Literature DB >> 30023342

Noninflammatory Diffuse Follicular Hypertrophy/Hyperplasia of Graves Disease: Morphometric Evaluation in an Experimental Mouse Model.

Anke Schlüter1,2, Anja K Eckstein1,3, Alexandra Brenzel4, Mareike Horstmann1, Stephan Lang2, Utta Berchner-Pfannschmidt1, J Paul Banga1, Salvador Diaz-Cano5.   

Abstract

OBJECTIVES: Experimental models of Graves hyperthyroid disease accompanied by Graves orbitopathy (GO) can be efficiently induced in susceptible inbred strains of mice by immunization by electroporation of heterologous human TSH receptor (TSHR) A-subunit plasmid. The interrelated pathological findings in the thyroid glands of Graves disease (GD) that explain the core changes classically include diffuse follicular hyperplasia and multifocal mild lymphocytic infiltrate. However, the relative contributions of different thyroid tissue components (colloid, follicular cells, and stroma) have not been previously evaluated. In this study, we characterize the thyroid gland of an experimental mouse model of autoimmune GD. Our objective was to define the relative contribution of the different thyroid tissue components to the pathology of glands in the experimental model.
METHODS: Mice were immunized with human TSHR A-subunit plasmid. Antibodies induced to human TSHR were pathogenic in vivo due to their cross-reactivity to mouse TSHR.
RESULTS: Autoimmune thyroid disease in the model was characterized by histopathology of hyperplastic glands with large follicular cells. Further examination of thyroid glands of immunized animals revealed a significantly increased follicular area and follicle/stroma ratio, morphometrically correlated with a noninflammatory follicular hyperplasia/hypertrophy. The increased follicle/stroma ratio was the most relevant morphometrically variable summarizing the pathological changes for screening purposes.
CONCLUSION: GD thyroid glands are enlarged and characterized by a noninflammatory diffuse follicular cell hyperplasia/hypertrophy and a significant increase in the follicles with an increased follicle/stroma ratio. Overall, this mouse model is a faithful model of an early hyperthyroid status of GD (diffuse glandular involvement and follicular expansion).

Entities:  

Keywords:  Follicular expansion; Glandular involvement; Graves disease; Hypertrophy/hyperplasia; Morphometric evaluation

Year:  2018        PMID: 30023342      PMCID: PMC6047491          DOI: 10.1159/000488079

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  30 in total

1.  Clinical-pathologic study of 76 cases of recurrent Graves' disease, toxic (non-exophthalmic) goiter, and nontoxic goiter; does a relation exist between thyroid hyperplasia and struma lymphomatosa?

Authors:  H J SPJUT; W D WARREN; L V ACKERMAN
Journal:  Am J Clin Pathol       Date:  1957-04       Impact factor: 2.493

2.  Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen.

Authors:  Utta Berchner-Pfannschmidt; Sajad Moshkelgosha; Salvador Diaz-Cano; Bärbel Edelmann; Gina-Eva Görtz; Mareike Horstmann; Alistair Noble; Wiebke Hansen; Anja Eckstein; J Paul Banga
Journal:  Endocrinology       Date:  2016-02-12       Impact factor: 4.736

Review 3.  NOD.H-2h4 mice: an important and underutilized animal model of autoimmune thyroiditis and Sjogren's syndrome.

Authors:  Helen Braley-Mullen; Shiguang Yu
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

4.  Adenomatous goiters with and without hyperthyroidism; some aspects of the relationship of the microscopic appearance to hyperthyroidism.

Authors:  J R JOHNSON
Journal:  Arch Surg       Date:  1949-11

5.  Control of human thyroid follicular cell proliferation in suspension and monolayer culture.

Authors:  D W Williams; D Wynford-Thomas; E D Williams
Journal:  Mol Cell Endocrinol       Date:  1987-05       Impact factor: 4.102

6.  Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.

Authors:  S Costagliola; M C Many; J F Denef; J Pohlenz; S Refetoff; G Vassart
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

7.  Shared and unique susceptibility genes in a mouse model of Graves' disease determined in BXH and CXB recombinant inbred mice.

Authors:  Sandra M McLachlan; Holly A Aliesky; Pavel N Pichurin; Chun-Rong Chen; Robert W Williams; Basil Rapoport
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

8.  Reaccumulation of thyroglobulin and colloid in rat and mouse thyroid follicles during intense thyrotropin stimulation. A clue to the pathogenesis of colloid goiters.

Authors:  H Gerber; H Studer; A Conti; H Engler; H Kohler; A Haeberli
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.

Authors:  Chun-Rong Chen; Pavel Pichurin; Yuji Nagayama; Francesco Latrofa; Basil Rapoport; Sandra M McLachlan
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice.

Authors:  Jeffrey C Flynn; Jacqueline A Gilbert; Chady Meroueh; Daniel P Snower; Chella S David; Yi-chi M Kong; J Paul Banga
Journal:  Immunology       Date:  2007-05-29       Impact factor: 7.397

View more
  1 in total

1.  The Association of Myo-Inositol and Selenium Contrasts Cadmium-Induced Thyroid C Cell Hyperplasia and Hypertrophy in Mice.

Authors:  Salvatore Benvenga; Antonio Micali; Antonio Ieni; Alessandro Antonelli; Poupak Fallahi; Giovanni Pallio; Natasha Irrera; Francesco Squadrito; Giacomo Picciolo; Domenico Puzzolo; Letteria Minutoli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.